How digital regulatory tools can accelerate your clinical performance study

by Wish Agency

Webinar - How digital regulatory tools can accelerate your clinical performance study

Between 33,000 and 42,200 European patients are expected to experience delayed access to clinical trials over the next 3 years as a result of IVDR.

Join us and learn how ARCs experts, supported by our digital regulatory navigation tools, can accelerate your clinical performance study approval.

What you’ll learn:

How the regulatory landscape has changed in key geographic markets and how it impacts device study approvals.
How to minimise the impact of IVDR on your precision medicine trials.
Strategies to expedite patient screening and keeping your clinical development programmes on track
Spotlight on ARC360, your online regulatory navigator to save you valuable time and resources.